Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

被引：0
作者：
Fardin Dolatimehr
Hamidreza Karimi-Sari
Mohammad Saeid Rezaee-Zavareh
Seyed Moayed Alavian
Bita Behnava
Mohammad Gholami-Fesharaki
Heidar Sharafi
机构：
[1] Student Research Committee,Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL)
[2] Baqiyatallah University of Medical Sciences,Department of Biostatistics, Faculty of Medical Sciences
[3] Meta-analysis Study Group,undefined
[4] Iran Hepatitis Network,undefined
[5] Baqiyatallah University of Medical Sciences,undefined
[6] Middle East Liver Disease (MELD) Center,undefined
[7] Tarbiat Modares University,undefined
来源：
DARU Journal of Pharmaceutical Sciences | / 25卷
关键词：
Hepatitis C; Sofosbuvir; Ribavirin; Pegylated-interferon; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
    Dolatimehr, Fardin
    Karimi-Sari, Hamidreza
    Rezaee-Zavareh, Mohammad Saeid
    Alavian, Seyed Moayed
    Behnava, Bita
    Gholami-Fesharaki, Mohammad
    Sharafi, Heidar
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 25
  • [2] Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis
    Bayatpoor, Mohammad Ehsan
    Khosravi, Mohammad Hossein
    Sharafi, Heidar
    Rezaee-Zavareh, Mohammad Saeid
    Behnava, Bita
    Alavian, Seyed Moayed
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2019, 14 (01):
  • [3] Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
    Rezaee-Zavareh, Mohammad Saeid
    Hesamizadeh, Khashayar
    Behnava, Bita
    Alavian, Seyed Moayed
    Gholami-Fesharaki, Mohammad
    Sharafi, Heidar
    ANNALS OF HEPATOLOGY, 2017, 16 (02) : 188 - 197
  • [4] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [5] Pegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta-analysis
    Aljumah, Abdulrahman A.
    Murad, Mohammad Hassan
    HEPATOLOGY RESEARCH, 2013, 43 (12) : 1255 - 1263
  • [6] Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis
    Zhang, Bing
    Nguyen, Nghia H.
    Yee, Brittany E.
    Yip, Benjamin
    Ayoub, Walid S.
    Lutchman, Glen A.
    Nguyen, Mindie H.
    INTERVIROLOGY, 2015, 58 (04) : 242 - 249
  • [7] Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis
    Ahmed, Hussien
    Abushouk, Abdelrahman I.
    Attia, Attia
    Gadelkarim, Mohamed
    Gabr, Mohamed
    Negida, Ahmed
    Abdel-Daim, Mohamed M.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (02) : 156 - 164
  • [8] Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis
    Thong, Vo Duy
    Poovorawan, Kittiyod
    Tangkijvanich, Pisit
    Wasitthankasem, Rujipat
    Vongpunsawad, Sompong
    Poovorawan, Yong
    INTERVIROLOGY, 2015, 58 (06) : 373 - 381
  • [9] Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis
    Tao, Tingting
    Jiang, Xuehua
    Chen, Yuehong
    Song, Yiran
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 55 : 56 - 71
  • [10] A fixed-dose combination of ledipasvir and sofosbuvir ± ribavirin for treatment of hepatitis C infection: a systematic review and meta-analysis
    Kunwar S.
    Devkota A.R.
    Ghimire D.K.C.
    Adhikari P.
    Drugs & Therapy Perspectives, 2017, 33 (7) : 348 - 360
12345